Home › Non-Small Cell Lung Cancer › South Carolina › Myrtle Beach
Non-Small Cell Lung Cancer clinical trials in Myrtle Beach, SC
4 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Myrtle Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- MUSC Hematology-Oncology at Murrells Inlet, Murrells Inlet · 13 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- MUSC Hematology-Oncology at Murrells Inlet, Murrells Inlet · 13 mi away
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #9, Myrtle Beach
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecruitingObservational study
- Carolina Urologic Research Center, Myrtle Beach
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX143 studies
- New York City, NY123 studies
- Arlington, VA111 studies
- Nashville, TN97 studies
- Los Angeles, CA92 studies
- Boston, MA87 studies
- St. Louis, MO68 studies
- Baltimore, MD60 studies
- San Antonio, TX60 studies
- Chicago, IL59 studies
- Columbus, OH57 studies
- Seattle, WA55 studies
Other studies in Myrtle Beach
- Prostate Cancer23 studies
- Non-Muscle Invasive Bladder Cancer10 studies
- Bladder Cancer10 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Urothelial (Transitional Cell) Carcinoma5 studies
- Metastatic Cancer5 studies
- Cancer (all types)4 studies
- Colorectal Cancer3 studies
- Type 2 Diabetes3 studies
- Carcinoma in Situ3 studies
- Castration-Resistant Prostatic Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.